# Author Correction: Revealing the pharmacological mechanisms of nao-an dropping pill in preventing and treating ischemic stroke via the PI3K/Akt/eNOS and Nrf2/HO-1 pathways

**Authors:** Chen Wang, Zhe-Ming Xiong, You-Quan Cong, Zi-Yao Li, Yi Xie, Ying-Xiao Wang, Hui-Min Zhou, Yan-Fang Yang, Jing-Jing Liu, He-Zhen Wu

PMC · DOI: 10.1038/s41598-025-94461-9 · 2025-04-08

## Full-text entities

- **Genes:** NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}
- **Diseases:** ischemic stroke (MESH:D002544)

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC11978771/full.md

---
Source: https://tomesphere.com/paper/PMC11978771